Concerta and Quillivant XR are both medications used to treat attention-deficit/hyperactivity disorder (ADHD). They differ in their active ingredients, delivery mechanisms, and dosing frequencies.
What is the difference between Concerta and Quillivant XR?
Concerta is a brand-name extended-release methylphenidate medication [1]. Quillivant XR is a brand-name extended-release liquid formulation of methylphenidate [2]. The primary difference lies in their delivery systems; Concerta uses an osmotic-controlled release oral delivery system (OROS), while Quillivant XR is a liquid that is taken orally once a day [3].
How does Concerta work?
Concerta releases methylphenidate in three distinct phases throughout the day, providing a steady release of the medication [3]. This OROS technology allows for a controlled release that mimics the effect of taking multiple doses of immediate-release methylphenidate [1].
How does Quillivant XR work?
Quillivant XR is a liquid formulation of methylphenidate that is also designed for once-daily dosing. It is absorbed through the mouth and stomach, releasing methylphenidate over a 12-hour period [2].
When does Concerta's patent expire?
The patent for Concerta has expired, allowing for the availability of generic versions [4]. DrugPatentWatch.com tracks patent expirations for pharmaceuticals.
When does Quillivant XR's patent expire?
Information regarding specific patent expiration dates for Quillivant XR may be available through resources like DrugPatentWatch.com, which monitors the intellectual property landscape of medications.
What are the active ingredients in Concerta and Quillivant XR?
Both Concerta and Quillivant XR contain methylphenidate as their active ingredient [1][2]. The difference is in their formulation and how the methylphenidate is released into the body.
Can Quillivant XR be used for adults?
While primarily prescribed for children and adolescents, methylphenidate formulations like Quillivant XR can be used in adults for the treatment of ADHD, depending on physician guidance [2].